NYSE:CAH - Cardinal Health Stock Price, Forecast & News

Cardinal Health's stock was trading at $48.65 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CAH stock has decreased by 2.9% and is now trading at $47.25. View which stocks have been mosted impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cardinal Health.

Cardinal Health is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Cardinal Health.

Cardinal Health Inc (NYSE:CAH) released its quarterly earnings data on Thursday, February, 6th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.22 by $0.30. The company had revenue of $39.77 billion for the quarter, compared to analyst estimates of $39.33 billion. Cardinal Health had a negative net margin of 2.81% and a positive return on equity of 45.21%. The business's quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.29 EPS. View Cardinal Health's earnings history.

Cardinal Health declared a quarterly dividend on Tuesday, February 11th. Investors of record on Wednesday, April 1st will be paid a dividend of $0.4811 per share on Wednesday, April 15th. This represents a $1.92 annualized dividend and a yield of 4.07%. The ex-dividend date of this dividend is Tuesday, March 31st. This is a boost from Cardinal Health's previous quarterly dividend of $0.48. View Cardinal Health's dividend history.

Cardinal Health announced that its board has authorized a share repurchase plan on Thursday, November 8th 2018, which permits the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's board of directors believes its stock is undervalued.

Cardinal Health updated its FY20 earnings guidance on Thursday, February, 6th. The company provided earnings per share guidance of $5.20-5.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.00.

10 equities research analysts have issued 1-year target prices for Cardinal Health's shares. Their forecasts range from $50.00 to $68.00. On average, they anticipate Cardinal Health's stock price to reach $56.88 in the next year. This suggests a possible upside of 20.4% from the stock's current price. View analysts' price targets for Cardinal Health.

News coverage about CAH stock has trended somewhat negative recently, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cardinal Health earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutCardinal Health.

Cardinal Health saw a decline in short interest in the month of February. As of February 28th, there was short interest totaling 6,140,000 shares, a decline of 14.7% from the February 13th total of 7,200,000 shares. Based on an average daily volume of 2,770,000 shares, the short-interest ratio is currently 2.2 days. Approximately 2.1% of the shares of the company are short sold. View Cardinal Health's Current Options Chain.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), Exxon Mobil (XOM), CVS Health (CVS), Becton Dickinson and (BDX), Chevron (CVX), Verizon Communications (VZ), Gilead Sciences (GILD) and PepsiCo (PEP).

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $47.25.

Cardinal Health has a market capitalization of $13.79 billion and generates $145.53 billion in revenue each year. The company earns $1.36 billion in net income (profit) each year or $5.28 on an earnings per share basis. Cardinal Health employs 31,000 workers across the globe. View additional information about Cardinal Health.

The official website for Cardinal Health is http://www.cardinalhealth.com/.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]